Delivery Order SPE2DX15D2012-SPE2DX24F7UG6
Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The $2,042.64 award has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to military treatment facilities worldwide....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,225.44 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML medication. The contract has a potential value of $1,225.44 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,225.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to supply a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The award has a completion date of February 23, 2024 and a potential value of $1,225.44. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of 4563881637 NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a potential value of $2,067.44 and a completion date of March 7, 2024. This award is not associated with a set-aside program. The contract is part of a larger indefinite delivery contract (IDC) awarded solely to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a potential value of $2,042.64 and a completion date of February 7, 2024. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and has also received...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order contract valued at $2,576.12 by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract is a firm fixed price delivery order with a completion date of February 14, 2024. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor for this order, which supports DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The award, valued at $1,225.44, has a completion date of February 7, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. The $1,900.65 award has a January 29, 2024 completion date and does not utilize any set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceuticals and medical supplies to support military...
- SPE2DX15D2012Indefinite Delivery Contract
- SPE2DX15D2012-SPE2DX24F7UG6Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, valued at $1,225.44. The contract has a completion date of February 1, 2024. This delivery order is one of many indefinite delivery contracts (IDCs) held by Amerisourcebergen Drug Corp with DLA, which serve as the primary vehicles for the company to deliver a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Generated 5/1/24, 10:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/31/24 |